Shikata, Hisaharu http://orcid.org/0000-0002-7605-7615
Kihara, Hisafumi
Kaneko, Masahiko
Matsukage, Shoichi
Hattori, Keiichiro
Article History
Received: 2 September 2020
Revised: 29 October 2020
Accepted: 9 November 2020
First Online: 22 November 2020
Compliance with ethical standards
:
: The authors have no conflicts of interest to declare.
: Off-label use of ibrutinib for this patient with BNS was approved by the Institutional Review Board of Uwajima City Hospital (IRB number: 1911-262). Written informed consent was also obtained from the patient for off-label use.